The cardiovascular component of MetS, particularly hypertension, is driven by a combination of endothelial dysfunction, hyperactivation of the sympathetic nervous system, increased expression of vasoconstrictors like endothelin-1, and overstimulation of the renin–angiotensin–aldosterone system (RAAS) [12]. Here, EDN1 is linked to metabolic syndrome.